2012•Unpublished venueRequires access

Point‐Of‐Care Testing in Hemostasis

Steve Kitchen, Dianne Patricia Kitchen

Open publisher page 0 citations

Abstract

Point-of-care (POC) testing in hemostasis has been in use for more than 50 years with a major expansion in recent years. Tests can be divided into either specific versions of conventional laboratory tests such as the international normalized ratio (INR) or activated partial thromboplastin time (APTT), global tests of hemostasis such as thromboelastography and activated clotting times, and tests of platelet function. Recently there has been a proliferation of devices for determination of the INR for monitoring of oral anticoagulant therapy with testing by many different types of healthcare professional and, more recently, patient self-testing and patient self-management. There has also been an increase in the number of devices in use for POC platelet function testing, in part because of the increased use of different antiplatelet agents. This chapter describes some general principles relevant to POC hemostasis testing as well as reviewing what is available in each of the specific areas of this field.

About this research paper

What this paper is about

Point-of-care (POC) testing in hemostasis has been in use for more than 50 years with a major expansion in recent years. Tests can be divided into either specific versions of conventional laboratory tests such as the international normalized ratio (INR) or activated partial thromboplastin time (APTT), global tests of hemostasis such as thromboelastography and activated clotting times, and tests of platelet function. Recently there has been a proliferation of devices for determination of the INR for monitoring of oral anticoagulant therapy with testing by many different types of healthcare professional and, more recently, patient self-testing and patient self-management. There has also been an increase in the number of devices in use for POC platelet function testing, in part because of the increased use of different antiplatelet agents. This chapter describes some general principles relevant to POC hemostasis testing as well as reviewing what is available in each of the specific areas of this field.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Point-of-care (POC) testing in hemostasis has been in use for more than 50 years with a major expansion in recent years. Tests can be divided into either specific versions of conventional laboratory tests such as the international normalized ratio (INR) or activated partial thromboplastin time (APTT), global tests of hemostasis such as thromboelastography and activated clotting times, and tests of platelet function. Recently there has been a proliferation of devices for determination of the INR for monitoring of oral anticoagulant therapy with testing by many different types of healthcare professional and, more recently, patient self-testing and patient self-management. There has also been an increase in the number of devices in use for POC platelet function testing, in part because of the increased use of different antiplatelet agents. This chapter describes some general principles relevant to POC hemostasis testing as well as reviewing what is available in each of the specific areas of this field.

Key concepts: Thromboelastography, Hemostasis, Partial thromboplastin time, Point-of-care testing, Medicine, Coagulation testing, Activated clotting time, Intensive care medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Point‐Of‐Care Testing in Hemostasis — Research Paper | ScholarLens